Genique Medcrop Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-06-2024
- Paid Up Capital ₹ 1.00 M
as on 17-06-2024
- Company Age 5 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.56 Cr
as on 17-06-2024
- Revenue 7.93%
(FY 2023)
- Profit 18.71%
(FY 2023)
- Ebitda 97.88%
(FY 2023)
- Net Worth 69.85%
(FY 2023)
- Total Assets 124.07%
(FY 2023)
About Genique Medcrop
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.56 Cr.
Mukesh Kumar and Het Ram serve as directors at the Company.
- CIN/LLPIN
U51909HR2019PTC084384
- Company No.
084384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Palwal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genique Medcrop Private Limited offer?
Genique Medcrop Private Limited offers a wide range of products and services, including Forceps & Graspers, Insufflators, Diagnostic Medical Imaging Equipment, ECG Machine, Surgical & ICU Equipments, CPAP, BiPAP Machine & Accessories, Endoscopy & Laparoscopy instruments, Laparoscopic Instruments, Endoscopy Instruments, Defibrillators.
Who are the key members and board of directors at Genique Medcrop?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Kumar  | Director | 26-Dec-2019 | Current |
| Het Ram | Director | 26-Dec-2019 | Current |
Financial Performance of Genique Medcrop.
Genique Medcrop Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.93% increase. The company also saw a substantial improvement in profitability, with a 18.71% increase in profit. The company's net worth Soared by an impressive increase of 69.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genique Medcrop?
In 2023, Genique Medcrop had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Dec 2023 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Jul 2023 | ₹0.36 M | Open |
Hdfc Bank Limited Creation Date: 03 May 2023 | ₹0.96 M | Open |
How Many Employees Work at Genique Medcrop?
Unlock and access historical data on people associated with Genique Medcrop, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genique Medcrop, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genique Medcrop's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
